vs
Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and Information Services Group Inc. (III). Click either name above to swap in a different company.
Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $61.2M, roughly 1.2× Information Services Group Inc.). Adaptive Biotechnologies Corp runs the higher net margin — 4.7% vs 4.4%, a 0.3% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 2.7%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs -2.4%).
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
ADPT vs III — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $70.9M | $61.2M |
| Net Profit | $3.4M | $2.7M |
| Gross Margin | 73.6% | — |
| Operating Margin | -27.1% | 8.2% |
| Net Margin | 4.7% | 4.4% |
| Revenue YoY | 35.1% | 2.7% |
| Net Profit YoY | — | 82.5% |
| EPS (diluted) | — | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $70.9M | $61.2M | ||
| Q4 25 | $71.7M | $61.2M | ||
| Q3 25 | $94.0M | $62.4M | ||
| Q2 25 | $58.9M | $61.6M | ||
| Q1 25 | $52.4M | $59.6M | ||
| Q4 24 | $47.5M | $57.8M | ||
| Q3 24 | $46.4M | $61.3M | ||
| Q2 24 | $43.2M | $64.3M |
| Q1 26 | $3.4M | $2.7M | ||
| Q4 25 | $-13.6M | $2.6M | ||
| Q3 25 | $9.5M | $3.1M | ||
| Q2 25 | $-25.6M | $2.2M | ||
| Q1 25 | $-29.9M | $1.5M | ||
| Q4 24 | $-33.7M | $3.0M | ||
| Q3 24 | $-32.1M | $1.1M | ||
| Q2 24 | $-46.2M | $2.0M |
| Q1 26 | 73.6% | — | ||
| Q4 25 | 74.6% | 44.8% | ||
| Q3 25 | 80.7% | 42.2% | ||
| Q2 25 | 69.4% | 42.2% | ||
| Q1 25 | 67.6% | 43.1% | ||
| Q4 24 | 62.0% | 41.5% | ||
| Q3 24 | 64.1% | 40.4% | ||
| Q2 24 | 55.3% | 39.5% |
| Q1 26 | -27.1% | 8.2% | ||
| Q4 25 | -17.8% | 8.4% | ||
| Q3 25 | 10.9% | 7.4% | ||
| Q2 25 | -42.5% | 7.6% | ||
| Q1 25 | -56.4% | 5.7% | ||
| Q4 24 | -71.3% | 0.3% | ||
| Q3 24 | -70.3% | 7.0% | ||
| Q2 24 | -109.6% | 5.7% |
| Q1 26 | 4.7% | 4.4% | ||
| Q4 25 | -18.9% | 4.3% | ||
| Q3 25 | 10.2% | 4.9% | ||
| Q2 25 | -43.5% | 3.5% | ||
| Q1 25 | -56.9% | 2.5% | ||
| Q4 24 | -71.0% | 5.3% | ||
| Q3 24 | -69.1% | 1.9% | ||
| Q2 24 | -107.0% | 3.2% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | $-0.08 | $0.06 | ||
| Q3 25 | $0.06 | $0.06 | ||
| Q2 25 | $-0.17 | $0.04 | ||
| Q1 25 | $-0.20 | $0.03 | ||
| Q4 24 | $-0.22 | $0.07 | ||
| Q3 24 | $-0.22 | $0.02 | ||
| Q2 24 | $-0.31 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $505.9M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $77.6M | — | ||
| Q4 25 | $70.5M | $28.7M | ||
| Q3 25 | $55.0M | $28.7M | ||
| Q2 25 | $43.2M | $25.2M | ||
| Q1 25 | $50.6M | $20.1M | ||
| Q4 24 | $47.9M | $23.1M | ||
| Q3 24 | $38.1M | $9.7M | ||
| Q2 24 | $59.8M | $11.8M |
| Q1 26 | — | — | ||
| Q4 25 | $218.8M | $94.7M | ||
| Q3 25 | $204.4M | $94.7M | ||
| Q2 25 | $179.7M | $94.1M | ||
| Q1 25 | $190.4M | $95.0M | ||
| Q4 24 | $202.7M | $96.3M | ||
| Q3 24 | $223.8M | $96.6M | ||
| Q2 24 | $241.6M | $95.5M |
| Q1 26 | $505.9M | — | ||
| Q4 25 | $512.7M | $211.0M | ||
| Q3 25 | $490.6M | $213.3M | ||
| Q2 25 | $496.6M | $200.7M | ||
| Q1 25 | $510.9M | $202.4M | ||
| Q4 24 | $539.4M | $204.5M | ||
| Q3 24 | $558.5M | $227.1M | ||
| Q2 24 | $584.9M | $235.3M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
